Backed by Ananda Impact Ventures and ReGen Ventures, along with Carbon13, Climate Capital, Better Ventures, CDTM Ventures, and several angel investors, the company aims to address structural inefficiencies in biomanufacturing. The technology targets challenges exacerbated by recent global events such as supply chain disruptions, disease-related shortages, and regulatory shifts in food and materials production.
The startup claims its platform can significantly reduce time and cost to scale. In one probiotic case study, Differential Bio reports achieving a 4x increase in biomass yield and a 16% reduction in production costs while…
